| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 9, 2025Virtual Press Office and PR Newswire: General Trade show news
TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE: TTI) announced that its senior management will be participating in the following investor conferences. Jefferies 11th Annual Virtual...
-
Dec 9, 2025Gartner Events Exhibitor news, photos, videos
New Feature Simplifies How Organizations Manage Applications Across Entire Edge Environments LAS VEGAS, Dec. 9, 2025 /PRNewswire/ -- Gartner IT Infrastructure, Operations & Cloud Strategies Conference
-
Dec 9, 2025CES Exhibitor News releases, photos and supporting content
Recently recognized with a CES 2026 Innovation Award, the solution combines video decoding, AI inference, and encoding on a single chip, offering 80% hardware cost savings compared to GPU...
-
Dec 9, 2025CES Exhibitor News releases, photos and supporting content
Hyundai Mobis to participate in CES 2026 next month… hosting an invitation-only private booth to focus on new business opportunities To be showcased: M.VICS 7.0 cockpit integrated solution,...
-
Dec 9, 2025Virtual Press Office and PR Newswire: General Trade show news
LBA-2: Primary results from VAYHIT2, a randomized, double-blind, phase 3 trial of ianalumab plus eltrombopag versus placebo plus eltrombopag in patients with primary immune thrombocytopenia (ITP)...
-
Dec 9, 2025Virtual Press Office and PR Newswire: General Trade show news
LBA-5: A hospital policy of tranexamic acid to reduce transfusion in major non-cardiac surgery: The TRACTION trial ORLANDO, Fla., Dec. 9, 2025 /PRNewswire/ -- When hospitals were randomly assigned...
-
Dec 9, 2025Virtual Press Office and PR Newswire: General Trade show news
LBA-3: Pirtobrutinib vs Bendamustine Plus Rituximab (BR) in Patients with CLL/SLL: First Results from a Randomized Phase III Study Examining a Non-Covalent BTK Inhibitor in Untreated Patients...
-
Dec 9, 2025Virtual Press Office and PR Newswire: General Trade show news
LBA-6: Phase 3 randomized study of teclistamab plus daratumumab versus investigator's choice of daratumumab and dexamethasone with either pomalidomide or bortezomib (DPd/DVd) in patients (Pts)...
-
Dec 9, 2025Virtual Press Office and PR Newswire: General Trade show news
Speakers and Exhibitors include Meta, Snap, AMD, HTC, Lenovo, Niantic Spatial, PICO, Siemens, Volkswagen, Novartis, Deutsche Telekom, Bosch, BBC, Airbus and more BRUSSELS, Dec. 9, 2025...
-
Dec 9, 2025Virtual Press Office and PR Newswire: General Trade show news
Today M&A Source® announces the results of the Fall 2025 Conference and Deal Market, held on November 11-12 in Phoenix, AZ. The event is an opportunity for lower middle market advisors and...
